Cocrystal intrinsic dissolution behavior using a rotating disk

Journal of Pharmaceutical Sciences

Volumn 100, Issue 5, 2011, Pages 1736-1744

  Lee, H G ^a   Zhang, Geoff G Z ^b   Flanagan, D R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Acetaminophen; Cocrystals; Complexation; Dissolution; Mathematical model; Precipitation; Solubility; Theophylline

Indexed keywords

PARACETAMOL; THEOPHYLLINE;

ARTICLE; CRYSTALLIZATION; DRUG MIXTURE; DRUG SOLUBILITY; THEORETICAL MODEL;

EID: 79952214468     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22400     Document Type: Article

References (27)

1. Higuchi T, Zuck DA. 1953. Investigation of some complexes formed in solution by caffeine. II. Benzoic acid and benzoate ion. J Am Pharm Assoc Sci 42:132-138.
2. Desiraju GR. 1995. Supramolecular synthons in crystal engineering - A new organic synthesis. Angew Chem Int Ed Engl 34:2311-2327.
3. Desiraju GR. 1989. Crystal engineering: The design of organic solids. New York, New York: Elsevier Science Publishing Co. Inc., pp 261-283.
4. Ma ZB, Moulton B. 2007. Mixed-ligand coordination species: A promising approach for "second-generation" drug development. Cryst Growth Des 7:196-198.
5. Ma ZB, Moulton B. 2007. Supramolecular medicinal chemistry: Mixed-ligand coordination complexes. Mol Pharm 4:373-385.
6. Shakeel F, Faisal MS. 2010. Caffeine: A potential complexing agent for solubility and dissolution enhancement of celecoxib. Pharm Biol 48:113-115.
7. Fleischman SG, Kuduva SS, McMahon JA, Moulton B, Walsh RDB, Rodríguez-Hornedo N, Zaworotko MJ. 2003. Crystal engineering of the composition of pharmaceutical phases: Multiple-component crystalline solids involving carbamazepine. Cryst Growth Des 3: 909-919.
8. Childs SL, Chyall LJ, Dunlap JT, Smolenskaya VN, Stahly BC, Stahly GP. 2004. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. J Am Chem Soc 126:13335-13342.
9. Rodriguez-Spong B. 2005. Enhancing the pharmaceutical behavior of poorly soluble drugs through the formation of cocrystals and mesophases. Ph.D. Thesis. Ann Arbor, Michigan: University of Michigan.
10. Nehm SJ, Rodriguez-Spong B, Rodriguez-Hornedo N. 2006. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation. Cryst Growth Des 6:592-600.
11. McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, Mannion R, O'Donnell E, Park A. 2006. Use of glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res 23:1888-1897.
12. Singh P, Desai SJ, Flanagan DR, Simonell AP, Higuchi WI. 1968. Mechanistic study of influence of micelle solubilization and hydrodynamic factors on dissolution rate of solid drugs. J Pharm Sci 57:959-965.
13. Mooney KG, Mintun MA, Himmelstein KJ, Stella VJ. 1981. Dissolution kinetics of carboxylic-acids 1. Effect of pH under unbuffered conditions. J Pharm Sci 70:13-22.
14. McNamara DP, Amidon GL. 1986. Dissolution of acidic and basic compounds from the rotating-disk - Influence of convective diffusion and reaction. J Pharm Sci 75:858-868.
15. Southard MZ, Green DW, Stella VJ, Himmelstein KJ. 1992. Dissolution of ionizable drugs into unbuffered solution - A comprehensive model for mass-transport and reaction in the rotating-disk geometry. Pharm Res 9:58-69.
16. Avdeef A, Tsinman O. 2008. Miniaturized rotating disk intrinsic dissolution rate measurement: Effects of buffer capacity in comparisons to traditional Wood's apparatus. Pharm Res 25:2613-2627.
17. Kuu WY, Prisco MR, Wood RW, Roseman TJ. 1989. Studies of dissolution behavior of highly soluble drugs using a rotating-disk. Int J Pharm 55:77-89.
18. Gregory DP, Riddiford AC. 1956. Transport to the surface of a rotating disc. J Chem Soc 3756-64.
19. Zhang GZ, Henry RF, Borchardt TB, Lou XC. 2007. Efficient co-crystal screening using solution-mediated phase transformation. J Pharm Sci 96:990-995.
20. Childs SL, Stahly GP, Park A. 2007. The salt-cocrystal continuum: The influence of crystal structure on ionization state. Mol Pharm 4:323-338.
21. Chafetz L, Daly RE, Schriftman H, Lomner JJ. 1971. Selective colorimetric determination of acetaminophen. J Pharm Sci 60:463-466.
22. Chow YP, Repta AJ. 1972. Complexation of acetaminophen with methyl xanthines. J Pharm Sci 61:1454-1458.
23. Sekiguchi K, Ito K. 1965. Studies on the molecular compounds of organic medicinals. I. Dissolution behavior of the molecular compound of sulfanilamide and sulfathiazole. Chem Pharm Bull 13:405-413.
24. Higuchi WI, Mir NA, Desai SJ. 1965. Dissolution rates of polyphase mixtures. J Pharm Sci 54:1405-1410.
25. McNamara DP, Amidon GL. 1988. Reaction plane approach for estimating the effects of buffers on the dissolution rate of acidic drugs. J Pharm Sci 77:511-517.
26. Levich VG. 1962. Physiochemical hydrodynamics. Englewood Cliffs, New Jersey: Prentice-Hall, pp 39-72.
27. Grassi M, Colombo I, Lapasin R. 2001. Experimental determination of the theophylline diffusion coefficient in swollen sodium-alginate membranes. J Control Release 76:93-105.